string(28) "" Next Page

Calculus backs Axol Bioscience with £2.5m

Axol Bioscience

  Private equity firm Calculus Capital, a leading EIS and VCT specialist, has invested £2.5m in Axol Bioscience (Axol). Cambridge-based Axol supplies high quality human cells – especially live human neurons – created by stem cell technology, to many of the world’s biggest and best-known pharma companies and research institutions. The cells, generated from blood […]

To read the full story Subscribe Sign in